aluates Reports

$ 0.0

Automative

Global Drug-Device Combination Products Market Research Report 2026

Published Date: 2026-03-30

Report Code: QYRE-Auto-33L12123

Global Drug Device Combination Products Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Drug-Device Combination Products Market Research Report 2026

Code: QYRE-Auto-33L12123

Report

2026-03-30

Pages:149

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medtronic Inc

Boston Scientific

Teleflex

Terumo

GSK

Novo Nordisk

Eli Lilly

Astrazeneca plc

Sanofi

Abbott

Boehringer Ingelheim

Hisamitsu

Smith & Nephew

Molnlycke

Lepu Medical

MicroPort

B. Braun

Antares Pharma

Viatris

Smith & Nephew

Drug-Device Combination Products Market Size

The global Drug-Device Combination Products market was valued at US$ 42710 million in 2025 and is anticipated to reach US$ 64700 million by 2032, at a CAGR of 6.2% from 2026 to 2032.

Drug-Device Combination Products Market

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.

Drivers of the Drug-Device Combination Products Market:

Growing Prevalence of Chronic Diseases: The rising incidence of chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders is fueling demand for drug-device combination products. These products, which combine medications with devices (like insulin pens or inhalers), offer more effective and patient-friendly treatment options.

Technological Advancements: Innovations in drug delivery technologies (e.g., smart drug delivery systems, micro-needles, and wearable injectors) have enhanced the efficiency and convenience of combination products. These innovations improve patient compliance and the precision of drug administration, driving market growth.

Increasing Geriatric Population: The global rise in the elderly population leads to greater demand for combination products. The elderly are more likely to suffer from multiple chronic conditions that require complex treatment regimes, which are often easier to manage with combination products.

Shift to Self-administration: Drug-device combination products enable patients to administer their medication at home, reducing the need for frequent hospital visits. This trend is particularly relevant during public health crises, like the COVID-19 pandemic, and supports growth in this market.

Regulatory Support: Regulatory authorities such as the FDA have provided specific pathways and guidance for the approval of drug-device combination products. This clarity supports product development and market entry.

Challenges in the Drug-Device Combination Products Market:

Complex Regulatory Approval Process: Despite some regulatory support, obtaining approval for drug-device combination products can be challenging. These products must meet both drug and device regulations, leading to potentially longer approval times and higher costs.

High Development Costs: The integration of drugs and devices often requires substantial investment in research, development, and clinical trials. This can be a barrier for smaller companies or startups trying to enter the market.

Risk of Product Recalls: Combination products are subject to the risks associated with both drugs and devices, such as manufacturing defects, quality issues, and adverse events. A problem with one component can lead to recalls, damaging a company’s reputation and finances.

Reimbursement and Pricing Issues: Securing reimbursement for combination products can be complex due to their dual nature. Payers may not readily classify or cover these products under standard reimbursement schemes, creating pricing challenges.

Patient Education and Compliance: Despite the benefits of self-administration, patients may struggle with proper use of combination products, leading to poor outcomes or misuse. Ensuring that patients are adequately educated about their use is a significant challenge.

Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific. In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.

This report delivers a comprehensive overview of the global Drug-Device Combination Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug-Device Combination Products. The Drug-Device Combination Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drug-Device Combination Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drug-Device Combination Products Market Report

Report Metric	Details
Report Name	Drug-Device Combination Products Market
Accounted market size in 2025	US$ 42710 million
Forecasted market size in 2032	US$ 64700 million
CAGR	6.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Drug-Coated Device Prefilled Drug Delivery Systems Nebulizer and Inhaler Transdermal Delivery System Others
Segment by Application	Hospital andClinic Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Viatris, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drug-Device Combination Products companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Drug-Device Combination Products Market growing?

Ans: The Drug-Device Combination Products Market witnessing a CAGR of 6.2% during the forecast period 2026-2032.

What is the Drug-Device Combination Products Market size in 2032?

Ans: The Drug-Device Combination Products Market size in 2032 will be US$ 64700 million.

What is the market share of major companies in Drug-Device Combination Products Market?

Ans: The top 3 companies hold a share about 32%.

Who are the main players in the Drug-Device Combination Products Market report?

Ans: The main players in the Drug-Device Combination Products Market are GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Viatris, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma

What are the Application segmentation covered in the Drug-Device Combination Products Market report?

Ans: The Applications covered in the Drug-Device Combination Products Market report are Hospital andClinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Drug-Device Combination Products Market report?

Ans: The Types covered in the Drug-Device Combination Products Market report are Drug-Coated Device, Prefilled Drug Delivery Systems, Nebulizer and Inhaler, Transdermal Delivery System, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Drug-Coated Device

1.2.3 Prefilled Drug Delivery Systems

1.2.4 Nebulizer and Inhaler

1.2.5 Transdermal Delivery System

1.2.6 Others

1.3 Market by Application

1.3.1 Global Drug-Device Combination Products Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital andClinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug-Device Combination Products Market Perspective (2021–2032)

2.2 Global Drug-Device Combination Products Growth Trends by Region

2.2.1 Global Drug-Device Combination Products Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Drug-Device Combination Products Historic Market Size by Region (2021–2026)

2.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2027–2032)

2.3 Drug-Device Combination Products Market Dynamics

2.3.1 Drug-Device Combination Products Industry Trends

2.3.2 Drug-Device Combination Products Market Drivers

2.3.3 Drug-Device Combination Products Market Challenges

2.3.4 Drug-Device Combination Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug-Device Combination Products Players by Revenue

3.1.1 Global Top Drug-Device Combination Products Players by Revenue (2021–2026)

3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2021–2026)

3.2 Global Top Drug-Device Combination Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Drug-Device Combination Products Revenue

3.4 Global Drug-Device Combination Products Market Concentration Ratio

3.4.1 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2025

3.5 Global Key Players of Drug-Device Combination Products Head Offices and Areas Served

3.6 Global Key Players of Drug-Device Combination Products, Products and Applications

3.7 Global Key Players of Drug-Device Combination Products, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Drug-Device Combination Products Breakdown Data by Type

4.1 Global Drug-Device Combination Products Historic Market Size by Type (2021–2026)

4.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2027–2032)

5 Drug-Device Combination Products Breakdown Data by Application

5.1 Global Drug-Device Combination Products Historic Market Size by Application (2021–2026)

5.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Drug-Device Combination Products Market Size (2021–2032)

6.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Drug-Device Combination Products Market Size by Country (2021–2026)

6.4 North America Drug-Device Combination Products Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug-Device Combination Products Market Size (2021–2032)

7.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Drug-Device Combination Products Market Size by Country (2021–2026)

7.4 Europe Drug-Device Combination Products Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Drug-Device Combination Products Market Size (2021–2032)

8.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region (2021–2026)

8.4 Asia-Pacific Drug-Device Combination Products Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Drug-Device Combination Products Market Size (2021–2032)

9.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Drug-Device Combination Products Market Size by Country (2021–2026)

9.4 Latin America Drug-Device Combination Products Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug-Device Combination Products Market Size (2021–2032)

10.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2021–2026)

10.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Drug-Device Combination Products Introduction

11.1.4 GSK Revenue in Drug-Device Combination Products Business (2021–2026)

11.1.5 GSK Recent Development

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Details

11.2.2 Novo Nordisk Business Overview

11.2.3 Novo Nordisk Drug-Device Combination Products Introduction

11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2021–2026)

11.2.5 Novo Nordisk Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Drug-Device Combination Products Introduction

11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2021–2026)

11.3.5 Eli Lilly Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Details

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Drug-Device Combination Products Introduction

11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2021–2026)

11.4.5 AstraZeneca Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Drug-Device Combination Products Introduction

11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2021–2026)

11.5.5 Sanofi Recent Development

11.6 Boston Scientific

11.6.1 Boston Scientific Company Details

11.6.2 Boston Scientific Business Overview

11.6.3 Boston Scientific Drug-Device Combination Products Introduction

11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2021–2026)

11.6.5 Boston Scientific Recent Development

11.7 Abbott

11.7.1 Abbott Company Details

11.7.2 Abbott Business Overview

11.7.3 Abbott Drug-Device Combination Products Introduction

11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2021–2026)

11.7.5 Abbott Recent Development

11.8 Boehringer Ingelheim

11.8.1 Boehringer Ingelheim Company Details

11.8.2 Boehringer Ingelheim Business Overview

11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction

11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2021–2026)

11.8.5 Boehringer Ingelheim Recent Development

11.9 Medtronic

11.9.1 Medtronic Company Details

11.9.2 Medtronic Business Overview

11.9.3 Medtronic Drug-Device Combination Products Introduction

11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2021–2026)

11.9.5 Medtronic Recent Development

11.10 Viatris

11.10.1 Viatris Company Details

11.10.2 Viatris Business Overview

11.10.3 Viatris Drug-Device Combination Products Introduction

11.10.4 Viatris Revenue in Drug-Device Combination Products Business (2021–2026)

11.10.5 Viatris Recent Development

11.11 3M

11.11.1 3M Company Details

11.11.2 3M Business Overview

11.11.3 3M Drug-Device Combination Products Introduction

11.11.4 3M Revenue in Drug-Device Combination Products Business (2021–2026)

11.11.5 3M Recent Development

11.12 Hisamitsu

11.12.1 Hisamitsu Company Details

11.12.2 Hisamitsu Business Overview

11.12.3 Hisamitsu Drug-Device Combination Products Introduction

11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2021–2026)

11.12.5 Hisamitsu Recent Development

11.13 Smith & Nephew

11.13.1 Smith & Nephew Company Details

11.13.2 Smith & Nephew Business Overview

11.13.3 Smith & Nephew Drug-Device Combination Products Introduction

11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2021–2026)

11.13.5 Smith & Nephew Recent Development

11.14 Molnlycke

11.14.1 Molnlycke Company Details

11.14.2 Molnlycke Business Overview

11.14.3 Molnlycke Drug-Device Combination Products Introduction

11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2021–2026)

11.14.5 Molnlycke Recent Development

11.15 Teleflex

11.15.1 Teleflex Company Details

11.15.2 Teleflex Business Overview

11.15.3 Teleflex Drug-Device Combination Products Introduction

11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2021–2026)

11.15.5 Teleflex Recent Development

11.16 BD

11.16.1 BD Company Details

11.16.2 BD Business Overview

11.16.3 BD Drug-Device Combination Products Introduction

11.16.4 BD Revenue in Drug-Device Combination Products Business (2021–2026)

11.16.5 BD Recent Development

11.17 Lepu Medical

11.17.1 Lepu Medical Company Details

11.17.2 Lepu Medical Business Overview

11.17.3 Lepu Medical Drug-Device Combination Products Introduction

11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2021–2026)

11.17.5 Lepu Medical Recent Development

11.18 MicroPort

11.18.1 MicroPort Company Details

11.18.2 MicroPort Business Overview

11.18.3 MicroPort Drug-Device Combination Products Introduction

11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2021–2026)

11.18.5 MicroPort Recent Development

11.19 Terumo

11.19.1 Terumo Company Details

11.19.2 Terumo Business Overview

11.19.3 Terumo Drug-Device Combination Products Introduction

11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2021–2026)

11.19.5 Terumo Recent Development

11.20 B. Braun

11.20.1 B. Braun Company Details

11.20.2 B. Braun Business Overview

11.20.3 B. Braun Drug-Device Combination Products Introduction

11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2021–2026)

11.20.5 B. Braun Recent Development

11.21 Antares Pharma

11.21.1 Antares Pharma Company Details

11.21.2 Antares Pharma Business Overview

11.21.3 Antares Pharma Drug-Device Combination Products Introduction

11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2021–2026)

11.21.5 Antares Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Boston Scientific

Teleflex

Terumo

GSK

Novo Nordisk

Eli Lilly

Astrazeneca plc

Sanofi

Abbott

Boehringer Ingelheim

Hisamitsu

Smith & Nephew

Molnlycke

Lepu Medical

MicroPort

B. Braun

Antares Pharma

Viatris

Smith & Nephew

List of Tables

Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Drug-Coated Device

Table 3. Key Players of Prefilled Drug Delivery Systems

Table 4. Key Players of Nebulizer and Inhaler

Table 5. Key Players of Transdermal Delivery System

Table 6. Key Players of Others

Table 7. Global Drug-Device Combination Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Drug-Device Combination Products Market Size by Region (US$ Million), 2021–2026

Table 10. Global Drug-Device Combination Products Market Share by Region (2021–2026)

Table 11. Global Drug-Device Combination Products Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Drug-Device Combination Products Market Share by Region (2027–2032)

Table 13. Drug-Device Combination Products Market Trends

Table 14. Drug-Device Combination Products Market Drivers

Table 15. Drug-Device Combination Products Market Challenges

Table 16. Drug-Device Combination Products Market Restraints

Table 17. Global Drug-Device Combination Products Revenue by Players (US$ Million), 2021–2026

Table 18. Global Drug-Device Combination Products Market Share by Players (2021–2026)

Table 19. Global Top Drug-Device Combination Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug-Device Combination Products Revenue, 2025

Table 20. Ranking of Global Top Drug-Device Combination Products Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Drug-Device Combination Products Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Drug-Device Combination Products, Headquarters and Area Served

Table 23. Global Key Players of Drug-Device Combination Products, Products and Applications

Table 24. Global Key Players of Drug-Device Combination Products, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Drug-Device Combination Products Market Size by Type (US$ Million), 2021–2026

Table 27. Global Drug-Device Combination Products Revenue Market Share by Type (2021–2026)

Table 28. Global Drug-Device Combination Products Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Drug-Device Combination Products Revenue Market Share by Type (2027–2032)

Table 30. Global Drug-Device Combination Products Market Size by Application (US$ Million), 2021–2026

Table 31. Global Drug-Device Combination Products Revenue Market Share by Application (2021–2026)

Table 32. Global Drug-Device Combination Products Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Drug-Device Combination Products Revenue Market Share by Application (2027–2032)

Table 34. North America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026

Table 36. North America Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Drug-Device Combination Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Drug-Device Combination Products Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Drug-Device Combination Products Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Drug-Device Combination Products Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Drug-Device Combination Products Market Size by Country (US$ Million), 2027–2032

Table 49. GSK Company Details

Table 50. GSK Business Overview

Table 51. GSK Drug-Device Combination Products Product

Table 52. GSK Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 53. GSK Recent Development

Table 54. Novo Nordisk Company Details

Table 55. Novo Nordisk Business Overview

Table 56. Novo Nordisk Drug-Device Combination Products Product

Table 57. Novo Nordisk Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 58. Novo Nordisk Recent Development

Table 59. Eli Lilly Company Details

Table 60. Eli Lilly Business Overview

Table 61. Eli Lilly Drug-Device Combination Products Product

Table 62. Eli Lilly Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 63. Eli Lilly Recent Development

Table 64. AstraZeneca Company Details

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Drug-Device Combination Products Product

Table 67. AstraZeneca Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 68. AstraZeneca Recent Development

Table 69. Sanofi Company Details

Table 70. Sanofi Business Overview

Table 71. Sanofi Drug-Device Combination Products Product

Table 72. Sanofi Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 73. Sanofi Recent Development

Table 74. Boston Scientific Company Details

Table 75. Boston Scientific Business Overview

Table 76. Boston Scientific Drug-Device Combination Products Product

Table 77. Boston Scientific Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 78. Boston Scientific Recent Development

Table 79. Abbott Company Details

Table 80. Abbott Business Overview

Table 81. Abbott Drug-Device Combination Products Product

Table 82. Abbott Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 83. Abbott Recent Development

Table 84. Boehringer Ingelheim Company Details

Table 85. Boehringer Ingelheim Business Overview

Table 86. Boehringer Ingelheim Drug-Device Combination Products Product

Table 87. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 88. Boehringer Ingelheim Recent Development

Table 89. Medtronic Company Details

Table 90. Medtronic Business Overview

Table 91. Medtronic Drug-Device Combination Products Product

Table 92. Medtronic Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 93. Medtronic Recent Development

Table 94. Viatris Company Details

Table 95. Viatris Business Overview

Table 96. Viatris Drug-Device Combination Products Product

Table 97. Viatris Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 98. Viatris Recent Development

Table 99. 3M Company Details

Table 100. 3M Business Overview

Table 101. 3M Drug-Device Combination Products Product

Table 102. 3M Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 103. 3M Recent Development

Table 104. Hisamitsu Company Details

Table 105. Hisamitsu Business Overview

Table 106. Hisamitsu Drug-Device Combination Products Product

Table 107. Hisamitsu Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 108. Hisamitsu Recent Development

Table 109. Smith & Nephew Company Details

Table 110. Smith & Nephew Business Overview

Table 111. Smith & Nephew Drug-Device Combination Products Product

Table 112. Smith & Nephew Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 113. Smith & Nephew Recent Development

Table 114. Molnlycke Company Details

Table 115. Molnlycke Business Overview

Table 116. Molnlycke Drug-Device Combination Products Product

Table 117. Molnlycke Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 118. Molnlycke Recent Development

Table 119. Teleflex Company Details

Table 120. Teleflex Business Overview

Table 121. Teleflex Drug-Device Combination Products Product

Table 122. Teleflex Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 123. Teleflex Recent Development

Table 124. BD Company Details

Table 125. BD Business Overview

Table 126. BD Drug-Device Combination Products Product

Table 127. BD Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 128. BD Recent Development

Table 129. Lepu Medical Company Details

Table 130. Lepu Medical Business Overview

Table 131. Lepu Medical Drug-Device Combination Products Product

Table 132. Lepu Medical Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 133. Lepu Medical Recent Development

Table 134. MicroPort Company Details

Table 135. MicroPort Business Overview

Table 136. MicroPort Drug-Device Combination Products Product

Table 137. MicroPort Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 138. MicroPort Recent Development

Table 139. Terumo Company Details

Table 140. Terumo Business Overview

Table 141. Terumo Drug-Device Combination Products Product

Table 142. Terumo Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 143. Terumo Recent Development

Table 144. B. Braun Company Details

Table 145. B. Braun Business Overview

Table 146. B. Braun Drug-Device Combination Products Product

Table 147. B. Braun Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 148. B. Braun Recent Development

Table 149. Antares Pharma Company Details

Table 150. Antares Pharma Business Overview

Table 151. Antares Pharma Drug-Device Combination Products Product

Table 152. Antares Pharma Revenue in Drug-Device Combination Products Business (US$ Million), 2021–2026

Table 153. Antares Pharma Recent Development

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

Table 157. Authors List of This Report

List of Figures

Figure 1. Drug-Device Combination Products Picture

Figure 2. Global Drug-Device Combination Products Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Drug-Device Combination Products Market Share by Type: 2025 vs 2032

Figure 4. Drug-Coated Device Features

Figure 5. Prefilled Drug Delivery Systems Features

Figure 6. Nebulizer and Inhaler Features

Figure 7. Transdermal Delivery System Features

Figure 8. Others Features

Figure 9. Global Drug-Device Combination Products Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Drug-Device Combination Products Market Share by Application: 2025 vs 2032

Figure 11. Hospital andClinic Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Other Case Studies

Figure 14. Drug-Device Combination Products Report Years Considered

Figure 15. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Drug-Device Combination Products Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Drug-Device Combination Products Market Share by Region: 2025 vs 2032

Figure 18. Global Drug-Device Combination Products Market Share by Players in 2025

Figure 19. Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Drug-Device Combination Products Revenue in 2025

Figure 21. North America Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Drug-Device Combination Products Market Share by Country (2021–2032)

Figure 23. United States Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Drug-Device Combination Products Market Share by Country (2021–2032)

Figure 27. Germany Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Drug-Device Combination Products Market Share by Region (2021–2032)

Figure 35. China Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Drug-Device Combination Products Market Share by Country (2021–2032)

Figure 43. Mexico Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Drug-Device Combination Products Market Share by Country (2021–2032)

Figure 47. Israel Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Drug-Device Combination Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 51. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 52. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 53. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 54. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 55. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 56. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 57. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 58. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 59. Viatris Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 60. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 61. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 62. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 63. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 64. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 65. BD Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 66. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 67. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 68. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 69. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 70. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2021–2026)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceutical and Medical Device Testing Market Research Report 2024

Global Combination Therapy Drug Market Research Report 2025

Global Ophthalmic Devices and Drugs Market Research Report 2025

Global Biologic Device Combination Products Market Research Report 2025

Global Drug device Combination Medical Device Market Research Report 2024

Global MedTech Devices Market Research Report 2025

Global Medical Device and Diagnostics Market Research Report 2025

Global Medicine Delivery Devices Market Research Report 2024

Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030

Global Diabetes Care Devices Drugs Market Research Report 2024

Combination Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Device Couplings Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Care Combination Products Market Research Report 2025

Integrated Drug Containment and Delivery Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global On body Drug Delivery Devices Market Research Report 2025

Analytical Instruments for Drug Screening Market

Global Medical Equipment Market Research Report 2025

Drug Screening Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global High Throughput Drug Screening Equipment Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions